Published Online
on February 9, 2004

A more recent version of this article appeared on April 1, 2004

This Article Full Text (PDF) All Versions of this Article: 43/4/832    most recent 01.HYP.0000119192.32360.a9v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alexander, B. T. Articles by Granger, J. P. Search for Related Content PubMed PubMed Citation Articles by Alexander, B. T. Articles by Granger, J. P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE NITRIC OXIDE Medline Plus Health Information High Blood Pressure High Risk Pregnancy Related Collections Animal models of human disease Other hypertension Hypertension - basic studies

Submitted on August 21, 2003
Revised on September 9, 2003

L-arginine Attenuates Hypertension in Pregnant Rats With Reduced Uterine Perfusion Pressure

Barbara T. Alexander; Maria T. Llinas; Walter C. Kruckeberg; and Joey P. Granger^*

From the Department of Physiology and Biophysics (B.T.A., M.T.L., J.P.G.), Department of Preventive Medicine (W.C.K.), and the Center for Excellence in Cardiovascular-Renal Research Center, University of Mississippi Medical Center, Jackson.

^* To whom correspondence should be addressed. E-mail: jgranger{at}physiology.umsmed.edu.

Abstract--A chronic reduction in uterine perfusion pressure in the pregnant rat is associated with significant elevations in mean arterial pressure, proteinuria, and reductions in kidney function as is chronic nitric oxide blockade, suggesting that nitric oxide deficiency may contribute to the clinical manifestations of preeclampsia. The purpose of this study was to determine whether supplementation with L-arginine, the precursor for nitric oxide, attenuates the hypertension produced in response to a chronic reduction in uterine perfusion pressure in the pregnant rat. Reduced uterine perfusion was initiated at day 14 of gestation with arterial pressure determined at day 19 of gestation in conscious, chronically instrumented rats. Arterial pressure was significantly elevated in pregnant rats with chronic reductions in uterine perfusion as compared with pregnant control rats (132±2 versus 109±2 mm Hg, P<0.01, respectively). Treatment with L-arginine (2%) in the drinking water was initiated at day 10 of gestation. L-arginine supplementation resulted in a significant decrease in arterial pressure in both pregnant rats with reduced uterine perfusion pressure (113±2 mm Hg treated, P<0.01 versus untreated pregnant with reduced uterine perfusion pressure) and pregnant control (97±3 mm Hg treated, P<0.01 versus untreated pregnant) rats. However, supplementation with L-arginine decreased blood pressure by 19 mm Hg in pregnant with reduced uterine perfusion pressure (untreated versus treated) as compared with 12 mm Hg in pregnant (untreated versus treated) rats. Thus, these results suggest that L-arginine supplementation may be beneficial in attenuating the hypertension in preeclampsia.

Key words: arginine • arterial pressure • hypertension, pregnancy • nitric oxide • preeclampsia

This article has been cited by other articles:

				J. S. Gilbert, S. A.B. Gilbert, M. Arany, and J. P. Granger Hypertension Produced by Placental Ischemia in Pregnant Rats Is Associated With Increased Soluble Endoglin Expression Hypertension, February 1, 2009; 53(2): 399 - 403. [Abstract] [Full Text] [PDF]

				P. Lopez-Jaramillo, W. D. Arenas, R. G. Garcia, M. Y. Rincon, and M. Lopez Review: The role of the L-arginine-nitric oxide pathway in preeclampsia Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 261 - 275. [Abstract] [PDF]

				B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF]

				J. S. Gilbert, M. J. Ryan, B. B. LaMarca, M. Sedeek, S. R. Murphy, and J. P. Granger Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H541 - H550. [Abstract] [Full Text] [PDF]

				J. S. Gilbert, S. A. Babcock, and J. P. Granger Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression Hypertension, December 1, 2007; 50(6): 1142 - 1147. [Abstract] [Full Text] [PDF]

				M. Hladunewich, S. A. Karumanchi, and R. Lafayette Pathophysiology of the Clinical Manifestations of Preeclampsia Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 543 - 549. [Full Text] [PDF]

				J. P. Granger Response to Modeling Preeclampsia: The True Model for the Uniquely Human Disease Preeclampsia Is the Human Female Not the Pregnant Rat Hypertension, April 1, 2007; 49(4): e22 - e22. [Full Text] [PDF]

				C. M. Anderson, F. Lopez, H.-Y. Zhang, Y. Shirasawa, K. Pavlish, and J. N. Benoit Mesenteric Vascular Responsiveness in a Rat Model of Pregnancy-Induced Hypertension Experimental Biology and Medicine, September 1, 2006; 231(8): 1398 - 1402. [Abstract] [Full Text] [PDF]

				M. Herrera, N. J. Hong, and J. L. Garvin Aquaporin-1 Transports NO Across Cell Membranes Hypertension, July 1, 2006; 48(1): 157 - 164. [Abstract] [Full Text] [PDF]

				C. Lam, K.-H. Lim, and S. A. Karumanchi Circulating Angiogenic Factors in the Pathogenesis and Prediction of Preeclampsia Hypertension, November 1, 2005; 46(5): 1077 - 1085. [Abstract] [Full Text] [PDF]

				M. Herrera and J. L. Garvin Recent Advances in the Regulation of Nitric Oxide in the Kidney Hypertension, June 1, 2005; 45(6): 1062 - 1067. [Abstract] [Full Text] [PDF]

				R. Dechend, P. Gratze, G. Wallukat, E. Shagdarsuren, R. Plehm, J.-H. Brasen, A. Fiebeler, W. Schneider, S. Caluwaerts, L. Vercruysse, et al. Agonistic Autoantibodies to the AT1 Receptor in a Transgenic Rat Model of Preeclampsia Hypertension, April 1, 2005; 45(4): 742 - 746. [Abstract] [Full Text] [PDF]

				G. Cherla and E. A. Jaimes Role of L-Arginine in the Pathogenesis and Treatment of Renal Disease J. Nutr., October 1, 2004; 134(10): 2801S - 2806S. [Abstract] [Full Text] [PDF]

				J. M. Davison, V. Homuth, A. Jeyabalan, K. P. Conrad, S. A. Karumanchi, S. Quaggin, R. Dechend, and F. C. Luft New Aspects in the Pathophysiology of Preeclampsia J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2440 - 2448. [Abstract] [Full Text] [PDF]

				A. M. Germain, G. Valdes, M. C. Romanik, and M. S. Reyes Letter to the Editor: Evidence Supporting a Beneficial Role for Long-Term L-Arginine Supplementation in High-Risk Pregnancies Hypertension, July 1, 2004; 44(1): e1 - e1. [Full Text] [PDF]